ORIGINAL ARTICLE

Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups

  1. G. F. PINEO1,
  2. A. S. GALLUS2,
  3. G. E. RASKOB3,
  4. D. CHEN4,
  5. L.-M. RAMIREZ4,
  6. E. RAMACCIOTTI4,
  7. M. R. LASSEN5,
  8. L. WANG4

Article first published online: 13 MAR 2013

DOI: 10.1111/jth.12109

Issue

Journal of Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis

Volume 11, Issue 3, pages 444–451, March 2013

Additional Information

How to Cite

PINEO, G. F., GALLUS, A. S., RASKOB, G. E., CHEN, D., RAMIREZ, L.-M., RAMACCIOTTI, E., LASSEN, M. R. and WANG, L. (2013), Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups. Journal of Thrombosis and Haemostasis, 11: 444–451. doi: 10.1111/jth.12109

Author Information

  1. 1

    Department of Medicine, University of Calgary, Calgary, AB, Canada

  2. 2

    SA Pathology at Flinders Medical Centre and Flinders University, Adelaide, SA, Australia

  3. 3

    College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK

  4. 4

    Research and Development, Bristol-Myers Squibb, Princeton, NJ, USA

  5. 5

    Spine Center Copenhagen, Clinical Trial Unit, Department 57, Glostrup Hospital, University of Copenhagen, Denmark

*Gary E. Raskob, College of Public Health, University of Oklahoma Health Sciences Center, 801 NE 13th Street, Oklahoma City, OK 73104, USA. Tel.: +1 405 271 2232; fax: +1 405 271 3039. E-mail gary-raskob@ouhsc.edu

Publication History

  1. Issue published online: 13 MAR 2013
  2. Article first published online: 13 MAR 2013
  3. Accepted manuscript online: 19 DEC 2012 11:16PM EST
  4. Received 17 August 2012, accepted 6 December 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS